insights_auto
Miks on SNW langenud? 3,44%?
Uurige põhjalikumaltchevron_right
SNW:ETR
Sanofi SA
70,70 €
arrow_downward
−3,44%(−2,52) 1 p
2. okt, 17:35:42 GMT +2 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse SNW põhistatistika genereerimine…
Ava
70,79 €
Kõrge
71,24 €
Madal
69,77 €
Turu kapit.
85,38 mld
Keskm. maht
11,43 tuh
Maht
44,02 tuh
Hinna ja tulu suhe
21,68
52 näd kõrgeim
90,75 €
52 näd madalaim
69,77 €
Aktsiatulu
3,26 €
Käibivad aktsiad
1,25 mld
Töötajate arv
75 tuh
Ava
70,79 €
Kõrge
71,24 €
Madal
69,77 €
Turu kapit.
85,38 mld
Keskm. maht
11,43 tuh
Maht
44,02 tuh
Hinna ja tulu suhe
21,68
52 näd kõrgeim
90,75 €
52 näd madalaim
69,77 €
Aktsiatulu
3,26 €
Käibivad aktsiad
1,25 mld
Töötajate arv
75 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
AD HOC NEWS
·
7 tunni eest
Regeneron expands Sanofi alliance. Regeneron stock trades at EUR 653.35.
AD HOC NEWS
·
8 tunni eest
Sanofi Shares Retreat as Investors Weigh Price Tag on Expanded Regeneron Alliance
AD HOC NEWS
·
15 tunni eest
Sanofi stock falls 3.13 percent as four antibodies join alliance
AD HOC NEWS
·
23 tunni eest
Sanofi's Pipeline Gamble: $8 Billion Regeneron Bet Weighs on Share Price
Profiil
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Teave üksuse Sanofi SA kohta
TegevjuhtPaul Hudson | Belén Garijo
Töötajad74,8 tuh
Asutatud1973
PeakontoridPariis, Île-de-France, Prantsusmaa
Sektor-
Veebisaitsanofi.com